Detalhe da pesquisa
1.
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial).
Ann Oncol
; 34(6): 520-530, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863483
2.
The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC).
Braz J Med Biol Res
; 51(3): e7214, 2018 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29340530